Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0001989644-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-11 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $10.88 | -610 | 103.1K | -0.6% | -$6,637 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-11 | F | D | 610 | $10.88 | 103,082 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |